These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31462260)

  • 1. Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis.
    Hu J; Wang W; Liu C; Li M; Nice E; Xu H
    J Exp Clin Cancer Res; 2019 Aug; 38(1):381. PubMed ID: 31462260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude mice.
    Yassin S; Hu J; Xu H; Li C; Setrerrahmane S
    Oncol Rep; 2016 Nov; 36(5):2951-2959. PubMed ID: 27633584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction Note: Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis.
    Hu J; Wang W; Liu C; Li M; Nice E; Xu H
    J Exp Clin Cancer Res; 2020 Feb; 39(1):35. PubMed ID: 32066476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant RGD-disintegrin DisBa-01 blocks integrin α
    Danilucci TM; Santos PK; Pachane BC; Pisani GFD; Lino RLB; Casali BC; Altei WF; Selistre-de-Araujo HS
    Cell Commun Signal; 2019 Mar; 17(1):27. PubMed ID: 30894182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral ischemia-induced angiogenesis is dependent on tumor necrosis factor receptor 1-mediated upregulation of α5β1 and αVβ3 integrins.
    Huang H; Huang Q; Wang F; Milner R; Li L
    J Neuroinflammation; 2016 Sep; 13(1):227. PubMed ID: 27586239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles for GP IIb/IIIa and αvβ3 integrins in MDA-MB-231 cell invasion and shear flow-induced cancer cell mechanotransduction.
    Zhao F; Li L; Guan L; Yang H; Wu C; Liu Y
    Cancer Lett; 2014 Mar; 344(1):62-73. PubMed ID: 24176823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HM-3-HSA exhibits potent anti-angiogenesis and antitumor activity in hepatocellular carcinoma.
    Li T; Ge G; Zhang H; Wang R; Liu Y; Zhang Q; Yue Z; Ma W; Li W; Zhang J; Yang H; Wang P; Zhao J; Fang Y; Xie Q; Wang M; Li Y; Zhu H; Li H
    Eur J Pharm Sci; 2021 Dec; 167():106017. PubMed ID: 34555448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of endothelial cell integrin function and angiogenesis by COX-2, cAMP and Protein Kinase A.
    Dormond O; Rüegg C
    Thromb Haemost; 2003 Oct; 90(4):577-85. PubMed ID: 14515176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
    Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
    Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
    Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
    Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
    Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockage of αvβ3 integrin in 3D culture of triple-negative breast cancer and endothelial cells inhibits migration and discourages endothelial-to-mesenchymal plasticity.
    Casali BC; Baptista MP; Pachane BC; Cortez AA; Altei WF; Selistre-de-Araújo HS
    Biochem Biophys Rep; 2024 Jul; 38():101686. PubMed ID: 38524278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor.
    Xie C; Wan X; Quan H; Zheng M; Fu L; Li Y; Lou L
    Cancer Sci; 2018 Apr; 109(4):1207-1219. PubMed ID: 29446853
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.